4.5 Article

Accuracy of imputation to infer unobserved APOE epsilon alleles in genorne-wide genotyping data

期刊

EUROPEAN JOURNAL OF HUMAN GENETICS
卷 22, 期 10, 页码 1239-1242

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2013.308

关键词

apolipoprotein E; APOE; epsilon alleles; GWAS; imputation

资金

  1. NIH-NINDS [R01NS059727]
  2. Keane Stroke Genetics Research Fund
  3. Edward and Maybeth Sonn Research Fund
  4. University of Michigan General Clinical Research Center [M01 RR000042]
  5. National Center for Research Resources
  6. NIH-NINDS SPOTRIAS fellowship [P50NS061343]
  7. American Brain Foundation
  8. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  9. National Institute on Aging
  10. National Institute of Biomedical Imaging and Bioengineering
  11. Alzheimer's Association
  12. Alzheimer's Drug Discovery Foundation
  13. BioClinica, Inc
  14. Biogen Idec Inc
  15. Bristol-Myers Squibb Company
  16. Eisai Inc
  17. Elan Pharmaceuticals, Inc
  18. Eli Lilly and Company
  19. F Hoffmann-La Roche Ltd
  20. Genentech, Inc
  21. GE Healthcare
  22. Irmogenetics, NV
  23. IXECO Ltd
  24. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  25. Johnson & Johnson Pharmaceutical Research & Development LLC
  26. Medpace, Inc
  27. Merck Co, Inc
  28. Meso Scale Diagnostics, LLC
  29. NeuroRx Research
  30. Novartis Pharmaceuticals Corporation
  31. Pfizer Inc
  32. Piramal Imaging
  33. Servier
  34. Synarc Inc
  35. Takeda Pharmaceutical Company
  36. Canadian Institutes of Health Research
  37. Foundation for the National Institutes of Health
  38. Northern California Institute for Research and Education
  39. NIH [P30 AG010129, K01 AG030514]

向作者/读者索取更多资源

Apolipoprotein E, encoded by APOE, is the main apoprotein for catabolism of chylomicrons and very low density lipoprotein. Two common single-nucleotide polymorphisms (SNPs) in APOE, rs429358 and rs7412, determine the three epsilon-alleles that are established genetic risk factors for late-onset Alzheimer's disease (AD), cerebral amyloid angiopathy, and intracerebral hemorrhage (ICH). These two SNPs are not present in most commercially available genome-wide genotyping arrays and cannot be inferred through imputation using HapMap reference panels. Therefore, these SNPs are often separately genotyped. Introduction of reference panels compiled from the 1000 Genomes project has made imputation of these variants possible. We compared the directly genotyped and imputed SNPs that define the APOE epsilon alleles to. determine the accuracy of imputation for inference of unobserved epsilon alleles. We utilized genome-wide genotype data obtained from two cohorts of ICH and AD constituting subjects of European ancestry. Our data suggest that imputation is highly accurate, yields an acceptable proportion of missing data that is non-differentially distributed across case and control groups, and generates comparable results to genotyped data for hypothesis testing. Further, we explored the effect of imputation algorithm parameters and demonstrated that customization of these parameters yields an improved balance between accuracy and missing data for inferred genotypes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据